{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:52:21Z","timestamp":1790092341486,"version":"4.0.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T00:00:00Z","timestamp":1711324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T00:00:00Z","timestamp":1711324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Accurate preoperative molecular and histological risk stratification is essential for effective treatment planning in endometrial cancer. However, inconsistencies between pre- and postoperative tumor histology have been reported in previous studies. To address this issue and identify risk factors related to inaccurate histologic diagnosis after preoperative endometrial evaluation, we conducted this retrospective analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a retrospective analysis involving 375 patients treated for primary endometrial cancer in five different gynaecological departments in Germany. Histological assessments of curettage and hysterectomy specimens were collected and evaluated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Preoperative histologic subtype was confirmed in 89.5% of cases and preoperative tumor grading in 75.2% of cases. Higher rates of histologic subtype variations (36.84%) were observed for non-endometrioid carcinomas. Non-endometrioid (OR 4.41) histology and high-grade (OR 8.37) carcinomas were identified as predictors of diverging histologic subtypes, while intermediate (OR 5.04) and high grading (OR 3.94) predicted diverging tumor grading.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>When planning therapy for endometrial cancer, the limited accuracy of endometrial sampling, especially in case of non-endometrioid histology or high tumor grading, should be carefully considered.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-024-12127-7","type":"journal-article","created":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T15:02:06Z","timestamp":1711378926000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Accuracy of endometrial sampling in the diagnosis of endometrial cancer: a multicenter retrospective analysis of the JAGO-NOGGO"],"prefix":"10.1186","volume":"24","author":[{"given":"Zaher","family":"Alwafai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0400-0046","authenticated-orcid":false,"given":"Maximilian Heinz","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepideh","family":"Fazeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"G\u00fcrtler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Kunz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"Singhartinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominika","family":"Trojnarska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Zocholl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Johannes","family":"Krankenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens-Uwe","family":"Blohmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalid","family":"Sehouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Pietzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,25]]},"reference":[{"issue":"3","key":"12127_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"10023","key":"12127_CR2","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","volume":"387","author":"P Morice","year":"2016","unstructured":"Morice P, Leary A, Creutzberg C, Abu-Rustum N, Darai E. Endometrial cancer. Lancet. 2016;387(10023):1094\u2013108.","journal-title":"Lancet"},{"key":"12127_CR3","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.2374","volume":"4","author":"JS Yuk","year":"2016","unstructured":"Yuk JS. The incidence rates of endometrial hyperplasia and endometrial cancer: a four-year population-based study. PeerJ. 2016;4: e2374.","journal-title":"PeerJ"},{"issue":"1","key":"12127_CR4","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1158\/1055-9965.EPI-14-0923","volume":"24","author":"B Trabert","year":"2015","unstructured":"Trabert B, Wentzensen N, Felix AS, Yang HP, Sherman ME, Brinton LA. Metabolic syndrome and risk of endometrial cancer in the united states: a study in the SEER-medicare linked database. Cancer Epidemiol Biomarkers Prev. 2015;24(1):261\u20137.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"16","key":"12127_CR5","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.2217\/fon.14.192","volume":"10","author":"MA Sheikh","year":"2014","unstructured":"Sheikh MA, Althouse AD, Freese KE, Soisson S, Edwards RP, Welburn S, et al. USA endometrial cancer projections to 2030: should we be concerned? Future Oncol. 2014;10(16):2561\u20138.","journal-title":"Future Oncol"},{"issue":"1","key":"12127_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","volume":"31","author":"N Concin","year":"2021","unstructured":"Concin N, Matias-Guiu X, Vergote I, Cibula D, Mirza MR, Marnitz S, et al. ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer. 2021;31(1):12\u201339.","journal-title":"Int J Gynecol Cancer"},{"issue":"29","key":"12127_CR7","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1200\/JCO.20.00549","volume":"38","author":"A Leon-Castillo","year":"2020","unstructured":"Leon-Castillo A, de Boer SM, Powell ME, Mileshkin LR, Mackay HJ, Leary A, et al. Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy. J Clin Oncol. 2020;38(29):3388\u201397.","journal-title":"J Clin Oncol"},{"issue":"2 Pt 1","key":"12127_CR8","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/AOG.0b013e318240de51","volume":"119","author":"MR Milam","year":"2012","unstructured":"Milam MR, Java J, Walker JL, Metzinger DS, Parker LP, Coleman RL, Gynecologic OG. Nodal metastasis risk in endometrioid endometrial cancer. Obstet Gynecol. 2012;119(2 Pt 1):286\u201392.","journal-title":"Obstet Gynecol"},{"issue":"5","key":"12127_CR9","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/sj.bjc.6603012","volume":"94","author":"CA Hamilton","year":"2006","unstructured":"Hamilton CA, Cheung MK, Osann K, Chen L, Teng NN, Longacre TA, et al. Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers. Br J Cancer. 2006;94(5):642\u20136.","journal-title":"Br J Cancer"},{"issue":"1","key":"12127_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","volume":"15","author":"JV Bokhman","year":"1983","unstructured":"Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol. 1983;15(1):10\u20137.","journal-title":"Gynecol Oncol"},{"key":"12127_CR11","doi-asserted-by":"crossref","unstructured":"Kasius JC, Pijnenborg JMA, Lindemann K, Forsse D, van Zwol J, Kristensen GB, et al. Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification. Cancers (Basel). 2021;13(22):5848.","DOI":"10.3390\/cancers13225848"},{"issue":"5","key":"12127_CR12","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1093\/annonc\/mdy058","volume":"29","author":"S Kommoss","year":"2018","unstructured":"Kommoss S, McConechy MK, Kommoss F, Leung S, Bunz A, Magrill J, et al. Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series. Ann Oncol. 2018;29(5):1180\u20138.","journal-title":"Ann Oncol"},{"issue":"9","key":"12127_CR13","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.annonc.2022.05.009","volume":"33","author":"A Oaknin","year":"2022","unstructured":"Oaknin A, Bosse TJ, Creutzberg CL, Giornelli G, Harter P, Joly F, et al. Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022;33(9):860\u201377.","journal-title":"Ann Oncol"},{"key":"12127_CR14","unstructured":"German German Guideline Program in Oncology (German Cancer Society GCA, AWMF). Endometrial Cancer, Long version 2.0, 2022. AWMF Registration Number: 032\/034-OL. 2022; https:\/\/www.leitlinienprogramm-onkologie.de\/leitlinien\/endometriumkarzinom\/. Accessed 17 Mar 2024."},{"issue":"4","key":"12127_CR15","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1097\/AOG.0000000000002261","volume":"130","author":"NCM Visser","year":"2017","unstructured":"Visser NCM, Reijnen C, Massuger L, Nagtegaal ID, Bulten J, Pijnenborg JMA. Accuracy of Endometrial Sampling in Endometrial Carcinoma: A Systematic Review and Meta-analysis. Obstet Gynecol. 2017;130(4):803\u201313.","journal-title":"Obstet Gynecol"},{"key":"12127_CR16","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejogrb.2015.09.004","volume":"194","author":"A Di Cello","year":"2015","unstructured":"Di Cello A, Rania E, Zuccala V, Venturella R, Mocciaro R, Zullo F, Morelli M. Failure to recognize preoperatively high-risk endometrial carcinoma is associated with a poor outcome. Eur J Obstet Gynecol Reprod Biol. 2015;194:153\u201360.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"12127_CR17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3109\/01443615.2014.935723","volume":"35","author":"MH Baek","year":"2015","unstructured":"Baek MH, Park YR, Suh DS, Lee SW, Park JY, Kim D, et al. Reliability of tumour grade 1 and endometrioid cell type on preoperative endometrial biopsy. J Obstet Gynaecol. 2015;35(1):79\u201381.","journal-title":"J Obstet Gynaecol"},{"issue":"3","key":"12127_CR18","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1006\/gyno.1999.5505","volume":"74","author":"FD Cirisano Jr","year":"1999","unstructured":"Cirisano FD Jr, Robboy SJ, Dodge RK, Bentley RC, Krigman HR, Synan IS, et al. Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma. Gynecol Oncol. 1999;74(3):385\u201394.","journal-title":"Gynecol Oncol"},{"issue":"9","key":"12127_CR19","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.ejso.2016.03.009","volume":"42","author":"TP Batista","year":"2016","unstructured":"Batista TP, Cavalcanti CL, Tejo AA, Bezerra AL. Accuracy of preoperative endometrial sampling diagnosis for predicting the final pathology grading in uterine endometrioid carcinoma. Eur J Surg Oncol. 2016;42(9):1367\u201371.","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"12127_CR20","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/IGC.0b013e3181a1a657","volume":"19","author":"JA Francis","year":"2009","unstructured":"Francis JA, Weir MM, Ettler HC, Qiu F, Kwon JS. Should preoperative pathology be used to select patients for surgical staging in endometrial cancer? Int J Gynecol Cancer. 2009;19(3):380\u20134.","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"12127_CR21","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/bjc.2013.766","volume":"110","author":"L Helpman","year":"2014","unstructured":"Helpman L, Kupets R, Covens A, Saad RS, Khalifa MA, Ismiil N, et al. Assessment of endometrial sampling as a predictor of final surgical pathology in endometrial cancer. Br J Cancer. 2014;110(3):609\u201315.","journal-title":"Br J Cancer"},{"issue":"8","key":"12127_CR22","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1097\/PAS.0b013e31825dd4b3","volume":"36","author":"O Fadare","year":"2012","unstructured":"Fadare O, Parkash V, Dupont WD, Acs G, Atkins KA, Irving JA, et al. The diagnosis of endometrial carcinomas with clear cells by gynecologic pathologists: an assessment of interobserver variability and associated morphologic features. Am J Surg Pathol. 2012;36(8):1107\u201318.","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"12127_CR23","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1097\/PAS.0b013e31827f576a","volume":"37","author":"CB Gilks","year":"2013","unstructured":"Gilks CB, Oliva E, Soslow RA. Poor interobserver reproducibility in the diagnosis of high-grade endometrial carcinoma. Am J Surg Pathol. 2013;37(6):874\u201381.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"12127_CR24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4132\/jptm.2020.10.04","volume":"55","author":"HJ Jung","year":"2021","unstructured":"Jung HJ, Lee SY, Hong JH, Chun YK. Interobserver diagnostic reproducibility in advanced-stage endometrial carcinoma. J Pathol Transl Med. 2021;55(1):43\u201352.","journal-title":"J Pathol Transl Med"},{"issue":"20","key":"12127_CR25","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1200\/JCO.2012.48.2596","volume":"31","author":"VW Setiawan","year":"2013","unstructured":"Setiawan VW, Yang HP, Pike MC, McCann SE, Yu H, Xiang YB, et al. Type I and II endometrial cancers: have they different risk factors? J Clin Oncol. 2013;31(20):2607\u201318.","journal-title":"J Clin Oncol"},{"issue":"9721","key":"12127_CR26","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/S0140-6736(09)62002-X","volume":"375","author":"Y Todo","year":"2010","unstructured":"Todo Y, Kato H, Kaneuchi M, Watari H, Takeda M, Sakuragi N. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet. 2010;375(9721):1165\u201372.","journal-title":"Lancet"},{"issue":"1","key":"12127_CR27","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ygyno.2016.07.090","volume":"143","author":"A Talhouk","year":"2016","unstructured":"Talhouk A, Hoang LN, McConechy MK, Nakonechny Q, Leo J, Cheng A, et al. Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: Earlier prognostic information to guide treatment. Gynecol Oncol. 2016;143(1):46\u201353.","journal-title":"Gynecol Oncol"},{"issue":"4","key":"12127_CR28","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/PGP.0000000000000334","volume":"36","author":"D Nastic","year":"2017","unstructured":"Nastic D, Shanwell E, Wallin KL, Valla M, Masback A, Mateoiu C, et al. A Selective Biomarker Panel Increases the Reproducibility and the Accuracy in Endometrial Biopsy Diagnosis. Int J Gynecol Pathol. 2017;36(4):339\u201347.","journal-title":"Int J Gynecol Pathol"},{"issue":"3","key":"12127_CR29","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/path.5375","volume":"250","author":"N Singh","year":"2020","unstructured":"Singh N, Piskorz AM, Bosse T, Jimenez-Linan M, Rous B, Brenton JD, et al. p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies. J Pathol. 2020;250(3):336\u201345.","journal-title":"J Pathol"},{"issue":"2","key":"12127_CR30","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/PAS.0000000000000764","volume":"41","author":"LN Hoang","year":"2017","unstructured":"Hoang LN, Kinloch MA, Leo JM, Grondin K, Lee CH, Ewanowich C, et al. Interobserver Agreement in Endometrial Carcinoma Histotype Diagnosis Varies Depending on The Cancer Genome Atlas (TCGA)-based Molecular Subgroup. Am J Surg Pathol. 2017;41(2):245\u201352.","journal-title":"Am J Surg Pathol"},{"issue":"Iss 1 Suppl 1","key":"12127_CR31","doi-asserted-by":"publisher","first-page":"S64","DOI":"10.1097\/PGP.0000000000000518","volume":"38 Suppl 1","author":"RA Soslow","year":"2019","unstructured":"Soslow RA, Tornos C, Park KJ, Malpica A, Matias-Guiu X, Oliva E, et al. Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists. Int J Gynecol Pathol. 2019;38 Suppl 1(Iss 1 Suppl 1):S64\u201374.","journal-title":"Int J Gynecol Pathol"}],"updated-by":[{"DOI":"10.1186\/s12885-024-12200-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T00:00:00Z","timestamp":1712102400000}}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12127-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-12127-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12127-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T07:02:22Z","timestamp":1712127742000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-12127-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,25]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["12127"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-12127-7","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12885-024-12200-1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,25]]},"assertion":[{"value":"27 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12885-024-12200-1","URL":"https:\/\/doi.org\/10.1186\/s12885-024-12200-1","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Ethics Committee of University of Greifswald, Germany (BB 109\/22; 12.05.2023). The waiver for informed consent to participate was given by the Institutional Ethics Committee of University of Greifswald, Germany.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent for participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"380"}}